Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Freeze-dried Haemophilus influenzae type b conjugate vaccine co-administration with DTaP-IPV: phase IV randomized open-label trial
CTR20241374Phase 4Active
- Sponsor
- Beijing Minhai Biological
- Start
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b disease (Hib), sponsored by Beijing Minhai Biological. Started Jul 2024; status: active.
02
Drugs
Haemophilus b conjugate vaccine
03
Conditions
Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20241374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241374.